-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Decibel Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2020 to Q2 2023.
- Decibel Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2023 was -$19M, a 11.3% decline year-over-year.
- Decibel Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2023 was -$66M, a 12.4% decline year-over-year.
- Decibel Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$64M, a 27.3% decline from 2021.
- Decibel Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$50.2M, a 27% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)